share_log

Apple's AirPods Pro 2 Bring 'Clinical-Grade Hearing Aid' Without The Stigma Or High Cost: Here's What People Have To Say

Apple's AirPods Pro 2 Bring 'Clinical-Grade Hearing Aid' Without The Stigma Or High Cost: Here's What People Have To Say

苹果的AirPods Pro 2带来了“临床级助听器”,没有附带的耻辱或高昂的费用:以下是人们对此的评论
Benzinga ·  04:01

On Monday, Apple Inc. (NASDAQ:AAPL) announced a new feature in its AirPods Pro 2, aiming to transform the hearing health experience. This feature will offer an end-to-end hearing health experience, including active Hearing Protection, a scientifically validated Hearing Test, and a clinical-grade Hearing Aid feature.

周一,苹果公司(纳斯达克股票代码:AAPL)宣布了其AirPods Pro 2的一项新功能,旨在改变听力健康体验。该功能将提供端到端的听力健康体验,包括主动听力保护、经过科学验证的听力测试和临床级助听器功能。

What Happened: With an estimated 1.5 billion people worldwide suffering from hearing loss, as per the World Health Organization, Apple has developed a comprehensive solution focused on prevention, awareness, and assistance.

发生了什么:根据世界卫生组织的数据,全球估计有15人患有听力损失,Apple 开发了一种侧重于预防、宣传和援助的全面解决方案。

The Hearing Protection feature will help users avoid exposure to loud environmental noise, while the Hearing Test feature will allow users to check their hearing at home. The results of this test will be used to create a personalized hearing profile for each user.

听力保护功能将帮助用户避免暴露在较大的环境噪音中,而听力测试功能将允许用户在家中检查听力。该测试的结果将用于为每位用户创建个性化的听力配置文件。

The typical prescription hearing aids cost $2,000 to $7,000 which makes them inaccessible to millions who need them.
In 2022, the FDA approved over the counter hearing aids. Now Apple's latest AirPods offer a hearing aid mode. Excited to see this technology become widely used! pic.twitter.com/ioI5KVbT5I

— Nick Mark MD (@nickmmark) September 9, 2024

典型的处方助听器售价为2,000至7,000美元,这使得数百万有需要的人无法获得它们。
2022年,美国食品药品管理局批准了非处方助听器。现在,苹果最新的AirPods提供了助听器模式。很高兴看到这项技术被广泛使用!pic.twitter.com/ioi5kvbt5I

— 尼克·马克医学博士 (@nickmmark) 2024 年 9 月 9 日

The Hearing Aid capability uses the personalized hearing profile to transform the AirPods Pro into a "clinical-grade hearing aid," boosting sounds in real-time to help users better engage in conversations and stay connected to their surroundings.

助听器功能使用个性化听力配置将 AirPods Pro 转变为 “临床级助听器”,实时增强声音,帮助用户更好地参与对话并与周围环境保持联系。

The Hearing Test and Hearing Aid features are expected to receive marketing authorization from global health authorities soon, including the U.S. Food and Drug Administration, and will be available this fall in more than 100 countries and regions.

听力测试和助听器功能预计将很快获得包括美国食品药品监督管理局在内的全球卫生当局的上市许可,并将于今年秋天在100多个国家和地区上市。

AirPods Pro 2 adding a clinical grade hearing aid functionality: Awesome

— Marques Brownlee (@MKBHD) September 9, 2024

AirPods Pro 2 增加了临床级助听器功能:太棒了

— 马克斯·布朗利 (@MKBHD) 2024 年 9 月 9 日

Why It Matters: This announcement follows a series of developments and hints in Apple's hearing health initiatives. In November 2022, a study published in the iScience journal suggested that AirPods Pro met four of five standards of personal sound amplification products, indicating their potential as a hearing assistive device.

为何重要:该公告是在苹果听力健康计划的一系列进展和提示之后发布的。2022年11月,发表在iScience期刊上的一项研究表明,AirPods Pro符合个人声音放大产品的五项标准中的四项,这表明它们作为助听设备的潜力。

The AirPods are now hearing aids, without the stigma of hearing aids.
If you have some hearing loss but don't want to be sporting hearing aids, you can now just throw in apple airpods and nobody is the wiser.

— Joseph Carlson (@joecarlsonshow) September 9, 2024

AirPods现在是助听器,没有助听器的污名。
如果你有听力损失但又不想使用助听器,你现在可以直接把苹果的airpods放进去,没有人比这更聪明了。

— 约瑟夫·卡尔森 (@joecarlsonshow) 2024 年 9 月 9 日

In March, rumors circulated about the new "hearing aid mode" for AirPods Pro in the upcoming iOS 18 update, building on the existing Live Listen feature.

3月,有传言称AirPods Pro在即将推出的iOS 18更新中将采用新的 “助听器模式”,该模式建立在现有的实时收听功能的基础上。

  • Mark Cuban Praises Elon Musk's AI Chatbot Grok For Answering Kamala Harris' POV On Immigration: 'I Think It's Accurate'
  • 马克·库班称赞埃隆·马斯克的人工智能聊天机器人 Grok 回答了卡玛拉·哈里斯关于移民的观点:“我认为这是准确的”

Image via Apple

图片来自苹果

Disclaimer: This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.

免责声明:此内容部分是在Benzinga Neuro的帮助下制作的,并由Benzinga编辑审查和发布。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发